Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Philip M. Short"'
Autor:
Margaret M Band, Hollian Richardson, Jennifer Pollock, Heather Barclay, Simon Finch, Gourab Chowdhury, Devesh Dhasmana, Philip M. Short, James D. Chalmers, Diane Cassidy, Rekha Chaudhuri, Mike Lonergan, Furrah Hussain, Andrew Mackenzie, Pauline Billingham, Alison Dicker, Andrew Paul Smith, Megan Crichton, Holly R. Keir, Clare Clarke, Mohammad Majid Paracha
Publikováno v:
Airway pharmacology and treatment.
Background: The MUSIC study is testing the impact of inhaled corticosteroid (ICS) and bronchodilator (LABA/LAMA) treatment on the upper and lower airway microbiome in patients with COPD (NCT02972476). Patients receiving ICS at baseline withdrew thera
Publikováno v:
Annals of Allergy, Asthma & Immunology. 118:179-185
Background Inhaled corticosteroid (ICS) titration in asthma is primarily based on symptoms and pulmonary function. ICSs may not be increased on this basis despite residual airway inflammation. Objective To compare the dose-response relationships of I
Autor:
William Anderson, Ashley Morrison, RW Kuo, RA Ross, Brian J. Lipworth, Sunny Jabbal, Philip M. Short
Publikováno v:
An update in lung physiology.
Background Beta-blockers (BB) are underused in COPD despite evidence for reducing mortality from cardiovascular comorbidities. Beta-1 selective antagonists such as bisoprolol (BIS) may cause bronchoconstriction due to dose related beta-2 blockade. Ce
Publikováno v:
Annals of Allergy, Asthma & Immunology. 115:17-20
Background Impulse oscillometry (IOS) is a novel method of assessing airway resistance. IOS is rarely used in assessing airway resistance after bronchoprovocation in adult asthma. Objective To ascertain the degree of change in IOS measurements seen i
Publikováno v:
Lung. 193:487-495
Left ventricular hypertrophy (LVH) is a significant cardiac risk factor, associated with increased mortality. The impact of LVH on mortality in chronic obstructive pulmonary disease (COPD) is unknown. We evaluated the impact of LVH on mortality in CO
Autor:
Sunny Jabbal, Philip M. Short, Brian Lipworth, William Anderson, Ashley Morrison, Arvind Manoharan
Publikováno v:
Airway Pharmacology and Treatment.
BACKGROUND Beta-blockers remain underused in patients with chronic obstructive pulmonary disease (COPD) and cardiovascular disease. AIM We compared how different inhaled therapies affect tolerability of bisoprolol and carvedilol in moderate to severe
Autor:
Philip M. Short, Peter A. Williamson, Arun Nair, Brian Lipworth, Lorna McKinlay, Patricia Burns
Publikováno v:
European journal of clinical pharmacology. 73(6)
Purpose This study compares the in vivo relative lung bioavailability of Hydrofluoroalkane (HFA) Seretide delivered via unprimed and unwashed Aerochamber Plus (AP) or Volumatic (VM) spacers, a integrated breath-actuated vortex Synchro-Breathe (SB) de
Publikováno v:
Clinical Science. 127:635-643
The murine asthma model shows that switching off airway β2 receptors with an inverse agonist may confer anti-inflammatory effects as well as corticosteroid-sparing activity. We have assessed for any corticosteroid-sparing effects of propranolol, an
Autor:
Aran Singanayagam, Stuart Schembri, Philip M. Short, James D. Chalmers, Michelle Harrison, Peter A. Williamson
Publikováno v:
Thorax. 69:609-615
Introduction Evidence suggests that platelets play a significant role in inflammation in addition to their role in thrombosis. Systemic inflammation is linked to poor short and long term outcomes in COPD. Increased platelet activation has been report
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 187:1308-1314
Rationale: Unblinded studies have shown improvements in airway hyperresponsiveness with chronic nadolol in steroid-naive patients with asthma.Objectives: To assess the effects of chronic nonselective β-blockade as add-on to inhaled corticosteroids (